Saturday 17 October 2026
Export HUM’s income statement to Excel — free account
Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
413.16
19.04
−4.41%
Follow HUM
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
49.65 | 14.99 | 23.41 | 18.16 | 16.11 | 20.35 | 22.60 | 23.59 | 25.40 | 26.03 |
Piotroski F-Score |
6 | 6 | 7 | 7 | 7 | 3 | 7 | 6 | 6 | 6 |
Altman Z-Score |
4.64 | 4.79 | 5.35 | 5.54 | 5.38 | 4.36 | 4.93 | 4.75 | 4.51 | 4.66 |
P/S ratio |
0.54 | 0.68 | 0.69 | 0.76 | 0.70 | 0.72 | 0.68 | 0.55 | 0.26 | 0.24 |
P/FCF ratio |
20.95 | 10.31 | 25.23 | 10.80 | 11.60 | 63.10 | 18.25 | 18.27 | 12.76 | 77.52 |
Altman Z″-Score (non-manufacturers) |
4.86 | 5.22 | 5.23 | 5.46 | 5.47 | 4.19 | 4.48 | 4.59 | 4.75 | 5.10 |
Beneish M-Score |
(2.58) | (3.16) | (2.49) | (2.78) | (2.77) | (1.62) | (2.86) | (2.43) | (2.29) | (2.29) |
P/Operating CF |
(10.64) | (12.49) | (118.28) | 95.96 | 191.65 | (621.80) | (12.34) | (8.16) | (57.94) | (18.68) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 61 |
P/B ratio |
2.76 | 3.69 | 3.88 | 4.08 | 3.95 | 3.71 | 4.12 | 3.57 | 1.86 | 1.74 |
Price to Tangible BV |
3.98 | 5.54 | 6.29 | 6.06 | 5.84 | 11.91 | 10.16 | 8.60 | 4.49 | 3.83 |
EV/Sales |
0.41 | 0.51 | 0.58 | 0.61 | 0.57 | 0.67 | 0.60 | 0.46 | 0.19 | 0.18 |
EV/EBITDA |
10.04 | 5.83 | 9.10 | 10.56 | 7.80 | 14.40 | 11.94 | 9.85 | 6.20 | 6.77 |
EV/Operating CF |
11.43 | 6.83 | 15.23 | 7.53 | 7.74 | 24.58 | 12.09 | 12.20 | 7.38 | 25.94 |
EV/FCF |
15.71 | 7.85 | 21.20 | 8.75 | 9.34 | 58.78 | 16.00 | 15.24 | 9.12 | 60.04 |
Quick Ratio |
1.63 | 1.54 | 1.33 | 1.47 | 1.37 | 1.20 | 1.20 | 1.24 | 1.37 | 1.42 |
Current Ratio |
2.07 | 1.85 | 1.68 | 1.82 | 1.77 | 1.62 | 1.52 | 1.59 | 1.76 | 2.00 |
Net Debt/EBITDA |
(3.35) | (1.83) | (1.73) | (2.48) | (1.89) | (1.06) | (1.68) | (1.96) | (2.47) | (2.14) |
Debt/Assets |
16.11% | 18.10% | 23.88% | 19.49% | 19.05% | 28.17% | 25.84% | 24.77% | 25.22% | 25.29% |
Debt/Equity |
0.38 | 0.50 | 0.60 | 0.47 | 0.49 | 0.78 | 0.72 | 0.71 | 0.71 | 0.70 |
Asset Turnover |
2.17 | 2.05 | 2.16 | 2.38 | 2.41 | 2.09 | 2.12 | 2.36 | 2.52 | 2.72 |
Operating CF/Net income |
3.15 | 1.65 | 1.29 | 1.95 | 1.67 | 0.77 | 1.63 | 1.60 | 2.46 | 0.78 |
Capex/Depreciation |
(1.13) | (1.08) | (1.15) | (1.28) | (1.56) | (1.85) | (1.33) | (0.87) | (0.59) | (0.63) |
Interest Coverage |
9.21 | 17.61 | 14.22 | 13.19 | 17.62 | 9.66 | 9.48 | 8.14 | 3.88 | 4.29 |
| 5.84% | 23.85% | 16.83% | 24.39% | 26.14% | 19.66% | 17.83% | 15.71% | 7.37% | 6.95% | |
| 2.45% | 9.31% | 6.40% | 9.94% | 10.51% | 7.39% | 6.42% | 5.52% | 2.58% | 2.49% | |
ROIC |
32.92% | 229.04% | 50.18% | 74.52% | 98.58% | 16.38% | 31.44% | 37.69% | 20.71% | 16.56% |
Return on Tangible Assets |
6.22% | 25.55% | 19.56% | 24.80% | 26.68% | 23.21% | 22.95% | 17.60% | 7.83% | 6.38% |
Average Days of Receivables |
8.59 | 5.80 | 6.51 | 5.94 | 5.38 | 7.97 | 6.58 | 6.98 | 8.38 | 9.20 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.13 | 0.12 | 0.15 | 0.14 | 0.13 | 0.25 | 0.21 | 0.20 | 0.21 | 0.20 |
Share Based Compensation of Revenue |
0.21% | 0.29% | 0.24% | 0.25% | 0.23% | 0.22% | 0.23% | 0.16% | 0.18% | 0.19% |
Graham Net Nets |
0.05 | 0.00 | 0.04 | 0.06 | 0.04 | (0.06) | (0.02) | (0.01) | (0.01) | 0.05 |
Graham Number |
80.04 | 160.41 | 142.67 | 201.92 | 243.90 | 253.31 | 246.16 | 243.05 | 175.09 | 180.56 |
Earnings Yield |
2.01% | 6.67% | 4.27% | 5.51% | 6.21% | 4.91% | 4.43% | 4.24% | 3.94% | 3.84% |
Free Cash Flow Yield |
4.77% | 9.70% | 3.96% | 9.26% | 8.62% | 1.58% | 5.48% | 5.47% | 7.84% | 1.29% |
Revenue per Share |
364.04 | 372.11 | 413.95 | 484.04 | 583.63 | 645.47 | 734.62 | 858.78 | 976.69 | 1,076.46 |
Operating CF per Share |
12.96 | 28.04 | 15.81 | 39.42 | 42.66 | 17.58 | 36.28 | 32.14 | 24.60 | 7.65 |
Capex per Share |
(3.53) | (3.63) | (4.45) | (5.49) | (7.29) | (10.23) | (8.86) | (6.41) | (4.71) | (4.34) |
Free Cash Flow per Share |
9.43 | 24.41 | 11.35 | 33.93 | 35.36 | 7.35 | 27.42 | 25.73 | 19.89 | 3.30 |
Cash per Share |
76.80 | 94.12 | 89.97 | 112.09 | 130.31 | 128.89 | 149.84 | 172.12 | 169.49 | 165.23 |
Shareholders Equity per Share |
71.53 | 68.11 | 73.91 | 89.79 | 103.84 | 125.13 | 121.58 | 131.74 | 136.39 | 147.25 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
71.53 | 68.11 | 73.91 | 89.79 | 103.84 | 125.13 | 121.58 | 131.74 | 136.39 | 147.25 |
Free Cash Flow |
1,409.00 | 3,527.00 | 1,561.00 | 4,548.00 | 4,675.00 | 946.00 | 3,467.00 | 3,187.00 | 2,398.00 | 398.00 |
Working Capital |
8,368.00 | 7,996.00 | 6,871.00 | 8,959.00 | 10,247.00 | 9,562.00 | 9,005.00 | 11,114.00 | 12,876.00 | 16,387.00 |
Capital Expenditures |
(527.00) | (524.00) | (612.00) | (736.00) | (964.00) | (1,316.00) | (1,120.00) | (794.00) | (568.00) | (523.00) |
Net Current Asset Value |
1,479.00 | 66.00 | 1,696.00 | 2,851.00 | 2,400.00 | (3,362.00) | (1,502.00) | (761.00) | (219.00) | 1,561.00 |
EV/EBIT |
12.72 | 6.49 | 10.67 | 12.46 | 8.76 | 17.66 | 14.59 | 12.10 | 8.54 | 8.84 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 |
Price to Operating Income |
16.95 | 8.53 | 12.71 | 15.39 | 10.88 | 18.96 | 16.65 | 14.51 | 11.94 | 11.41 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.31 | 0.31 | 0.31 | 0.29 | 0.26 | 0.23 | 0.26 | 0.30 | 0.38 | 0.37 |
Cash ROIC |
5.37% | 12.44% | 5.46% | 13.90% | 12.43% | 2.09% | 7.63% | 6.47% | 4.93% | 0.80% |
Accounts Receivable Turnover |
44.55 | 50.39 | 60.90 | 62.66 | 70.33 | 56.28 | 53.25 | 57.36 | 49.70 | 43.41 |
Accounts Payable Turnover |
19.24 | 13.31 | 12.86 | 15.79 | 15.87 | 16.24 | 15.53 | 14.97 | 17.02 | 20.19 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
20.01 | 34.15 | 24.40 | 25.44 | 23.77 | 23.78 | 25.26 | 27.13 | 19.07 | 18.83 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1,220.50 | 1,067.00 | 934.50 | 1,035.50 | 1,097.00 | 1,476.00 | 1,744.00 | 1,854.50 | 2,369.50 | 2,987.00 |
Average Payables |
2,339.50 | 3,268.00 | 3,568.00 | 3,410.50 | 3,883.50 | 4,261.00 | 4,873.50 | 5,903.50 | 5,914.00 | 5,488.00 |
Average Assets |
25,037.00 | 26,287.00 | 26,295.50 | 27,243.50 | 32,021.50 | 39,663.50 | 43,706.50 | 45,060.00 | 46,772.00 | 47,694.00 |
Average Common Equity |
10,515.50 | 10,263.50 | 10,001.50 | 11,099.00 | 12,882.50 | 14,915.50 | 15,736.50 | 15,844.00 | 16,381.50 | 17,091.00 |
Columns are period end dates